The FDA tracker is a section of Amino Axiom, a free research information platform, that works as a regulatory-status reference for research compounds. A researcher looks up a compound and reads the status recorded for it. It is available at the Amino Axiom FDA tracker.
For supplier vetting, the page answers a narrow question: what regulatory standing does a compound carry at the time of review. That is context for a sourcing record. It does not say anything about a particular vendor or a particular vial, and this FAQ stays within what the page visibly shows.
What does a status entry tell a sourcing researcher?
A status entry tells a researcher where a compound sits from a regulatory standpoint on the date the page was read. It is a category label attached to a compound, so it applies equally to every vendor that supplies that compound. It does not rate any supplier or any batch.
That limit shapes how the entry should be used. A sourcing file benefits from knowing a compound's standing because regulatory context can affect which suppliers continue to list it, how they word their labels and how long a supply line is likely to be stable. The entry is background for those judgments, not a result of them.
It also helps to separate two questions that are easy to blur. The first is what a compound is, which is fixed by its molecular identity. The second is how a compound is currently treated, which can change. The tracker speaks to the second. The first is settled by identifiers and analytical evidence.
Why does regulatory status matter for supplier vetting?
Status matters because sourcing decisions are made against a moving background. A compound's regulatory standing can shift, and suppliers respond to those shifts by changing listings, labeling or whether they carry a compound at all. A researcher who recorded the status on the review date can later tell whether a change in availability coincided with a change in standing or came from something else.
Our overview of FDA peptide enforcement in 2026 describes how enforcement activity shaped the supplier landscape, and the tracker is a compact way to see the status side of that picture for a single compound.
Three practical reasons stand out:
Records age. A status noted in an old purchase file may no longer match what the tracker shows.
Suppliers differ in how they handle the same status, so the same entry can accompany very different documentation.
Auditing a sourcing file later is easier when the status and the date of the lookup are written down together.
How does the tracker connect to a specific compound?
A worked example keeps this concrete. Take BPC-157, a 15-residue synthetic peptide that Onward Aminos lists with CAS 137525-51-0, molecular weight 1419.56 g/mol and formula C62H98N16O22. A researcher vetting a supplier for this compound can follow a short sequence:
Look up the compound on the tracker and note the status shown.
Record the date of the lookup beside the status.
Obtain the batch's certificate of analysis from the supplier.
Compare the identifiers on that certificate with the reference values above: CAS, molecular weight and formula.
File the status note and the identifier check together.
The status and the identifiers answer different questions. The status is contextual and can change. The identifiers are stable, so they give a fixed yardstick for the document in hand. If the numbers on a certificate disagree with the reference values, the status of the compound does not resolve that; only the supplier or further analysis can.
The same sequence applies to Selank, listed with CAS 129954-34-3, molecular weight 751.86 g/mol and formula C33H57N9O15, or to TB500, listed with CAS 885340-08-9, molecular weight 868.99 g/mol and formula C38H68N10O14. Only the reference values change from one compound to the next.
How should two status entries be compared?
Comparing two compounds side by side is a common vetting task, and the main risk is reading a difference in status as a difference in material quality. It is not. Two compounds with different statuses can both be supplied as thoroughly documented material, and two compounds with the same status can differ widely in documentation from one supplier to the next.
A cleaner comparison uses two columns in a sourcing file. The first column holds the status on the date of review. The second holds the analytical record for the batch in hand: certificate, chromatogram, mass spectrometry identity and the identifier check against reference values. Reading across a row then shows whether a compound's contextual note and its batch evidence tell a consistent story, while keeping each type of information in its own lane.
When the two columns seem to disagree, the right response is to gather more information rather than to infer. A status can be recent while a certificate is older, or the reverse. Dates on both columns make that visible at a glance and prevent a stale entry from being mistaken for a current one.
What belongs in the file next to a status?
A status note is most useful when it sits beside the records it gives context to. Five items cover most needs: the compound name, its catalog identifiers, the status as read, the date of the lookup and the batch reference the note relates to. Together they let a later reader reconstruct what was known at the time of sourcing without repeating the research.
Identifiers deserve particular care. CAS number, molecular weight and formula should be copied from a catalog or a certificate, never retyped from memory, because a single transposed digit in a CAS number produces a different registry entry. Checking a copied value against a second source takes a minute and removes a class of silent error.
Finally, the file should say who made the entry. When more than one person handles procurement, an initial and a date on each note make it clear whether a status was read once and reused or rechecked, and they make hand-offs between lab members cleaner.
What can a status tracker not tell a researcher?
The tracker has three limits. Each one marks the point where status information ends and batch verification begins. A researcher should keep all three in mind when reading an entry.
A status is not a quality assessment. A compound can carry a given status and be supplied as well-characterized material by one vendor and as poorly documented material by another. The status says nothing about which.
A status is a point-in-time record. What the tracker shows today may differ next quarter, so a lookup supports a decision only on the day it is made. A long project should repeat the check and log the date.
A status does not substitute for batch verification. Whether a given vial matches its stated identity and purity is determined by analytical evidence for that batch. Our explanation of HPLC purity testing covers what a chromatographic figure does and does not establish, and our guide to COA recordkeeping covers how to keep that evidence organized next to the status note.
How can the tracker be folded into a sourcing checklist?
A short addition to an existing vetting checklist is enough. Before a compound is added to a procurement list, look up its status and record the date. Before an older record is relied on, check whether the status has changed since the record was written. When a status differs from what an earlier note says, write down both, so the history can be read later without repeating the lookup.
It is also worth keeping the lookup separate from the verification in the file. One section holds the contextual note: status and date. A second section holds the analytical evidence: certificate, chromatogram and identifier comparison. Mixing the two tends to produce notes where a status is quietly treated as evidence of quality.
The tracker pairs naturally with the platform's other status information. Our write-up of the vendor status tracker covers the supplier-side view, while the FDA tracker covers the compound-side view. Amino Axiom describes itself as a research information and tracking platform, and both are best used in that spirit: an organized record of status and timing, with verification resting on batch documentation. The platform's homepage is at Amino Axiom for readers who want wider context.
Summary
The FDA tracker records the regulatory status of research compounds so that a sourcing file can note it with a date. It gives context that ages, so the lookup should be repeated and logged. It says nothing about vendor quality or batch identity. The dependable pattern is to check status, record the date, then verify the batch against published identifiers and file both outcomes together.
This article is provided for informational and laboratory research purposes only. The compounds discussed are research chemicals intended for in vitro and laboratory use. They are not drugs, supplements or food, and are not intended to diagnose, treat, cure or prevent any disease. Onward Aminos does not sell products intended for human use. Researchers are responsible for compliance with all applicable local, state and federal regulations. Amino Axiom is an independent research information platform. For research purposes only.
Reference
Common questions
It is a regulatory-status tracker for research compounds. A researcher looks up a compound and reads the status recorded for it. It describes where a compound sits from a regulatory standpoint, not whether a particular vial matches its label or how pure it is. For research purposes only.
Status gives context for sourcing records. A compound's regulatory standing can shift over time, and a sourcing file that notes the status on the date of review is easier to audit later. It is one input among several and does not measure batch identity or purity. For research purposes only.
No. Status attaches to a compound or category, not to a supplier's batch. Two vendors can supply the same compound under the same status and differ widely in documentation. Identity and purity are established by analytical evidence for the specific batch. For research purposes only.
A status is a snapshot, so a long-running project should repeat the lookup and record the date each time. The tracker reflects what it records at the moment it is read. A note reading checked on a given date is more useful later than a bare status word. For research purposes only.
Stay in the loop
New compounds, research updates & exclusive subscriber deals.
Skip to main content
